Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel L Batterham

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Eclinicalmedicine|January 8, 2026
Patient and clinician perspectives on the management of obesity in kidney failure prior to kidney transplantation: a mixed-methods systematic reviewZhanna Oganesova, Helen L MacLaughlin, Kieran McCafferty, et al.
Diabetes Care|October 12, 2023
Predictors of ≥15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1-4Maciej T Małecki, Rachel L Batterham, Naveed Sattar, et al.
Diabetes|February 5, 2011
Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YYKeval Chandarana, Cigdem Gelegen, Efthimia Karra, et al.
Plos One|March 26, 2013
Differential pre-mRNA splicing regulates Nnat isoforms in the hypothalamus after gastric bypass surgery in miceWilliam R Scott, Cigdem Gelegen, Keval Chandarana, et al.
Plos One|August 17, 2013
Contribution of 32 GWAS-identified common variants to severe obesity in European adults referred for bariatric surgeryReedik Mägi, Sean Manning, Ahmed Yousseif, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 12, 2020
Diet during early life defines testicular lipid content and sperm quality in adulthoodLuís Crisóstomo, Romeu A Videira, Ivana Jarak, et al.
Clinical Obesity|January 12, 2025
Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trialsDeborah B Horn, Scott Kahan, Rachel L Batterham, et al.
The New England Journal of Medicine|September 5, 2003
Inhibition of food intake in obese subjects by peptide YY3-36Rachel L Batterham, Mark A Cohen, Sandra M Ellis, et al.
Diabetes, Obesity & Metabolism|April 13, 2023
New insights into the treatment of obesityMatthias Blüher, Mohini Aras, Louis J Aronne, et al.
The American Journal of Clinical Nutrition|September 11, 2019
A randomized crossover trial assessing the effects of acute exercise on appetite, circulating ghrelin concentrations, and butyrylcholinesterase activity in normal-weight males with variants of the obesity-linked FTO rs9939609 polymorphismJames L Dorling, David J Clayton, Jenny Jones, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Eclinicalmedicine|January 8, 2026
Patient and clinician perspectives on the management of obesity in kidney failure prior to kidney transplantation: a mixed-methods systematic reviewZhanna Oganesova, Helen L MacLaughlin, Kieran McCafferty, et al.
Diabetes Care|October 12, 2023
Predictors of ≥15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1-4Maciej T Małecki, Rachel L Batterham, Naveed Sattar, et al.
Diabetes|February 5, 2011
Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YYKeval Chandarana, Cigdem Gelegen, Efthimia Karra, et al.
Plos One|March 26, 2013
Differential pre-mRNA splicing regulates Nnat isoforms in the hypothalamus after gastric bypass surgery in miceWilliam R Scott, Cigdem Gelegen, Keval Chandarana, et al.
Plos One|August 17, 2013
Contribution of 32 GWAS-identified common variants to severe obesity in European adults referred for bariatric surgeryReedik Mägi, Sean Manning, Ahmed Yousseif, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 12, 2020
Diet during early life defines testicular lipid content and sperm quality in adulthoodLuís Crisóstomo, Romeu A Videira, Ivana Jarak, et al.
Clinical Obesity|January 12, 2025
Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trialsDeborah B Horn, Scott Kahan, Rachel L Batterham, et al.
The New England Journal of Medicine|September 5, 2003
Inhibition of food intake in obese subjects by peptide YY3-36Rachel L Batterham, Mark A Cohen, Sandra M Ellis, et al.
Diabetes, Obesity & Metabolism|April 13, 2023
New insights into the treatment of obesityMatthias Blüher, Mohini Aras, Louis J Aronne, et al.
The American Journal of Clinical Nutrition|September 11, 2019
A randomized crossover trial assessing the effects of acute exercise on appetite, circulating ghrelin concentrations, and butyrylcholinesterase activity in normal-weight males with variants of the obesity-linked FTO rs9939609 polymorphismJames L Dorling, David J Clayton, Jenny Jones, et al.
Pageof 15